デフォルト表紙
市場調査レポート
商品コード
1677885

医薬品自動化市場規模、シェア、成長分析:提供別、自動化モード別、エンドユーザー別、用途別、地域別 - 産業予測 2025~2032年

Pharmaceutical Automation Market Size, Share, and Growth Analysis, By Offering (Hardware, Software), By Mode of Automation (Fully-Automated Systems, Semi-Automated Systems), By End User, By Application, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医薬品自動化市場規模、シェア、成長分析:提供別、自動化モード別、エンドユーザー別、用途別、地域別 - 産業予測 2025~2032年
出版日: 2025年03月07日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品自動化の世界市場規模は、2023年に75億6,000万米ドルと評価され、2024年の83億8,000万米ドルから2032年には190億3,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは10.8%で成長する見通しです。

高度な分析とソフトウェアを搭載した薬局自動化装置は、世界の小売薬局の状況を変革し、収益性と効率を大幅に向上させています。自動化の導入は、薬剤師のワークフロー管理を簡素化し、患者の満足度を優先させる一方で、投薬の無駄を大幅に削減し、1回あたりの投薬コストを引き下げています。処方薬や市販薬の価格が高騰する中、製薬会社は自動化を活用し、品質や安全性を損なうことなく生産量を増やしています。この技術革新は、COVID-19パンデミックの間に支持を得たフレキシブルオートメーションやデジタル化のような既存の動向と一致し、より迅速で柔軟な生産ライン構築を可能にします。全体として、自動化への推進は業界を再形成し、厳しい市場環境の中で持続可能な成長のために企業を位置づけています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 規制情勢

医薬品自動化市場規模:提供別& CAGR(2025-2032)

  • 市場概要
  • ハードウェア
  • ソフトウェア
  • サービス

医薬品自動化市場規模:自動化モード別& CAGR(2025-2032)

  • 市場概要
  • 完全自動化システム
  • 半自動システム

医薬品自動化市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 製薬会社
  • 調査室
  • 契約製造組織(CMO)
  • 契約調査機関(CRO)

医薬品自動化市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 創薬
  • 医薬品開発
  • 臨床試験
  • 製造業
  • 包装
  • 品質管理

医薬品自動化市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Becton, Dickinson and Company(USA)
  • Baxter International Inc.(USA)
  • Siemens Healthineers(Germany)
  • GE Healthcare(USA)
  • Omnicell, Inc.(USA)
  • Swisslog Healthcare(Switzerland)
  • Capsa Healthcare(USA)
  • Parata Systems(USA)
  • ARxIUM(Canada)
  • ScriptPro LLC(USA)
  • Yuyama Co., Ltd.(Japan)
  • McKesson Corporation(USA)
  • Pearson Medical Technologies(USA)
  • Accu-Chart Plus Healthcare Systems(USA)
  • NewIcon(Finland)
  • AlixaRx(USA)
  • KUKA AG(Germany)
  • TOSHO Inc.(Japan)
  • Cerner Corporation(USA)

結論と提言

目次
Product Code: SQMIG35A2186

Global Pharmaceutical Automation Market size was valued at USD 7.56 billion in 2023 and is poised to grow from USD 8.38 billion in 2024 to USD 19.03 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

Pharmacy automation devices, powered by advanced analytics and software, are transforming the global retail pharmacy landscape, enhancing profitability and efficiency significantly. The adoption of automation has drastically cut medication waste, lowering the cost per dose, while simplifying workflow management for pharmacists and prioritizing patient satisfaction. In light of skyrocketing prices for prescription and over-the-counter medications, pharmaceutical companies are leveraging automation to boost production without compromising quality or safety. This innovation enables faster and more flexible production line construction, aligning with existing trends like flexible automation and digitalization that gained traction during the COVID-19 pandemic. Overall, the push toward automation is reshaping the industry and positioning companies for sustainable growth amidst challenging market conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Automation Market Segments Analysis

Global Pharmaceutical Automation Market is segmented by Offering, Mode of Automation, End User, Application and region. Based on Offering, the market is segmented into Hardware, Software and Services. Based on Mode of Automation, the market is segmented into Fully-Automated Systems and Semi-Automated Systems. Based on End User, the market is segmented into Pharmaceutical Companies, Research Laboratories, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on Application, the market is segmented into Drug Discovery, Drug Development, Clinical Trials, Manufacturing, Packaging and Quality Control. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Automation Market

The Global Pharmaceutical Automation market is experiencing significant growth due to several key factors. Increasing integration of robotics in pharmaceutical manufacturing, government initiatives aimed at advancing industrial development, and heightened investments focused on upgrading conventional production facilities are driving this trend. Moreover, there is a surging consumer demand for safe and digitized production methods, which further fuels the adoption of automation technologies. This combination of technological advancement and changing market expectations is creating a robust environment for growth within the pharmaceutical automation sector, paving the way for innovative solutions and improved operational efficiencies in the industry.

Restraints in the Global Pharmaceutical Automation Market

The Global Pharmaceutical Automation market faces obstacles, yet it is projected that the significant demand for COVID-19 vaccine production, coupled with the increasing integration of Internet of Things (IoT) technologies in pharmaceutical manufacturing, will create considerable opportunities for industry growth. This trend highlights the dual impact of current healthcare needs and technological advancements, suggesting that while challenges exist, the potential for innovation and expansion in pharmaceutical automation is promising. As companies adapt to meet these demands, the landscape of the market is likely to evolve, offering prospects for improved efficiency and effectiveness in drug manufacturing processes.

Market Trends of the Global Pharmaceutical Automation Market

The global pharmaceutical automation market is experiencing significant growth, driven by an escalating demand for advanced technologies that minimize medication errors and enhance operational efficiency. Increasing regulatory pressure for safety and accuracy in drug production, coupled with a heightened focus on patient safety, is propelling investments in automation solutions. Additionally, the ongoing digital transformation, especially post-pandemic, has led to a surge in the adoption of artificial intelligence and robotics within pharmacies. This convergence of factors is fostering innovative solutions, streamlining workflows, and enabling better inventory management, ultimately contributing to the robust expansion of the pharmaceutical automation landscape worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Pharmaceutical Automation Market Size by Offering & CAGR (2025-2032)

  • Market Overview
  • Hardware
  • Software
  • Services

Global Pharmaceutical Automation Market Size by Mode of Automation & CAGR (2025-2032)

  • Market Overview
  • Fully-Automated Systems
  • Semi-Automated Systems

Global Pharmaceutical Automation Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical Companies
  • Research Laboratories
  • Contract Manufacturing Organizations (CMOs)
  • Contract Research Organizations (CROs)

Global Pharmaceutical Automation Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Drug Discovery
  • Drug Development
  • Clinical Trials
  • Manufacturing
  • Packaging
  • Quality Control

Global Pharmaceutical Automation Market Size & CAGR (2025-2032)

  • North America (Offering, Mode of Automation, End User, Application)
    • US
    • Canada
  • Europe (Offering, Mode of Automation, End User, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Offering, Mode of Automation, End User, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Offering, Mode of Automation, End User, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Offering, Mode of Automation, End User, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omnicell, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Swisslog Healthcare (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Capsa Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Parata Systems (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARxIUM (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScriptPro LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yuyama Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pearson Medical Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accu-Chart Plus Healthcare Systems (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NewIcon (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AlixaRx (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • KUKA AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TOSHO Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations